- Home
- AIMD vs TLPH Comparison
AIMD vs TLPH Comparison
Compare AIMD & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- TLPH
- Stock Information
- Founded
- AIMD 1984
- TLPH 2005
- Country
- AIMD United States
- TLPH United States
- Employees
- AIMD N/A
- TLPH N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- AIMD Health Care
- TLPH Health Care
- Exchange
- AIMD Nasdaq
- TLPH Nasdaq
- Market Cap
- AIMD 11.9M
- TLPH 11.1M
- IPO Year
- AIMD N/A
- TLPH 2011
- Fundamental
- Price
- AIMD $3.63
- TLPH $0.52
- Analyst Decision
- AIMD
- TLPH Strong Buy
- Analyst Count
- AIMD 0
- TLPH 1
- Target Price
- AIMD N/A
- TLPH $6.00
- AVG Volume (30 Days)
- AIMD 235.1K
- TLPH 3.4M
- Earning Date
- AIMD 08-13-2025
- TLPH 08-14-2025
- Dividend Yield
- AIMD N/A
- TLPH N/A
- EPS Growth
- AIMD N/A
- TLPH N/A
- EPS
- AIMD N/A
- TLPH N/A
- Revenue
- AIMD $110,870.00
- TLPH $27,000.00
- Revenue This Year
- AIMD N/A
- TLPH N/A
- Revenue Next Year
- AIMD N/A
- TLPH $14,533.26
- P/E Ratio
- AIMD N/A
- TLPH N/A
- Revenue Growth
- AIMD 70.25
- TLPH N/A
- 52 Week Low
- AIMD $2.00
- TLPH $0.38
- 52 Week High
- AIMD $5.00
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- AIMD 54.86
- TLPH 58.16
- Support Level
- AIMD $3.56
- TLPH $0.40
- Resistance Level
- AIMD $4.19
- TLPH $0.57
- Average True Range (ATR)
- AIMD 0.27
- TLPH 0.07
- MACD
- AIMD -0.01
- TLPH 0.00
- Stochastic Oscillator
- AIMD 38.46
- TLPH 44.50
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.